Literature DB >> 29481944

Prior Endovascular Intervention Is Not Detrimental to Pedal Bypasses for Ischemic Wounds.

Abhisekh Mohapatra1, Mikayla N Lowenkamp2, Jon C Henry2, Aureline Boitet2, Efthimios D Avgerinos2, Rabih A Chaer2, Michel S Makaroun2, Steven A Leers2, Eric S Hager2.   

Abstract

BACKGROUND: Endovascular strategies are often preferred for revascularization of ischemic foot wounds secondary to infrapopliteal disease because of the less invasive technique and faster recovery. Bypass is typically reserved for failures or lesions not amenable to balloon angioplasty. However, the effects of an endovascular-first approach on subsequent bypass grafts are largely unknown. This study evaluates the effects of prior endovascular tibial interventions (PTIs) on successive bypasses to pedal targets.
METHODS: Patients who presented with ischemic tissue loss and tibial arterial occlusive disease to University of Pittsburgh Medical Center between 2006 and 2013 and underwent a surgical bypass to pedal arteries were included in this study. A retrospective chart review was conducted to obtain patient demographics, past medical history, extent of disease, prior tibial endovascular interventions, the treatment intervention, subsequent interventions, wound healing status, limb salvage, and patient survival. The primary outcome was primary patency of the pedal bypass graft.
RESULTS: From 122 eligible patients, 27 had a PTI, whereas 95 had no prior endovascular tibial intervention (nPTI) in the treatment of ischemic pedal wounds with mean follow-up of 24.5 and 20.5 months, respectively (P = 0.36). The 2 groups were largely similar in terms of demographics, comorbidities, wound size, and degree of ischemia. Runoff scores between the 2 groups were also comparable (5.0 ± 1.6 for PTI and 4.8 ± 1.9 for nPTI, P = 0.59). The plantar artery was a more common target vessel in the PTI group, whereas the posterior tibial artery was targeted more often in the nPTI group (P = 0.04). At 12 months, those with a PTI exhibited a shorter primary patency (34.8% vs. 60.2%, P = 0.04). In a multivariate model, PTI was a significant risk factor for primary patency loss (hazard ratio 2.51, P = 0.004). Primary assisted patency and secondary patency were similar between the 2 groups. Wound healing was improved in those patients who had a prior endovascular intervention with 63.8% healed at 1 year compared with only 34.8% of those without intervention (P = 0.01). Amputation-free survival was similar (P = 0.68), as was survival alone (P = 0.50).
CONCLUSIONS: Despite a decrease in primary patency, pedal bypass was not otherwise negatively affected by a PTI. Similar primary assisted patency, secondary patency, wound healing, and survival between the 2 patient populations indicate that an endovascular-first approach is a feasible treatment strategy to achieve similar clinical outcomes in the management of ischemic foot wounds.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29481944      PMCID: PMC6014906          DOI: 10.1016/j.avsg.2017.11.066

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  13 in total

Review 1.  Patterns of disease distribution of lower extremity peripheral arterial disease.

Authors:  Qian Chen; Yang Shi; Yutang Wang; Xiaoying Li
Journal:  Angiology       Date:  2014-03-19       Impact factor: 3.619

2.  Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis.

Authors:  Maria I Söderström; Eva M Arvela; Maria Korhonen; Karoliina H Halmesmäki; Anders N Albäck; Fausto Biancari; Mauri J Lepäntalo; Maarit A Venermo
Journal:  Ann Surg       Date:  2010-11       Impact factor: 12.969

Review 3.  Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.

Authors:  Ehrin J Armstrong; Kalkidan Bishu; Stephen W Waldo
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

4.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

5.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

Review 6.  Endovascular intervention for tibial artery occlusive disease in patients with critical limb ischemia.

Authors:  Zhen S Huang; Darren B Schneider
Journal:  Semin Vasc Surg       Date:  2014-12-18       Impact factor: 1.000

Review 7.  The natural history of untreated severe or critical limb ischemia.

Authors:  Abd Moain Abu Dabrh; Mark W Steffen; Chaitanya Undavalli; Noor Asi; Zhen Wang; Mohamed B Elamin; Michael S Conte; Mohammad Hassan Murad
Journal:  J Vasc Surg       Date:  2015-09-26       Impact factor: 4.268

8.  Angioplasty versus bypass surgery in patients with critical limb ischemia-a meta-analysis.

Authors:  Xiaoyang Fu; Zhidong Zhang; Kai Liang; Shuaitao Shi; Guoquan Wang; Kewei Zhang; Kun Li; Weixiao Li; Tianxiao Li; Shuiting Zhai
Journal:  Int J Clin Exp Med       Date:  2015-07-15

9.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).

Authors:  Joseph L Mills; Michael S Conte; David G Armstrong; Frank B Pomposelli; Andres Schanzer; Anton N Sidawy; George Andros
Journal:  J Vasc Surg       Date:  2013-10-12       Impact factor: 4.268

Review 10.  Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.

Authors:  Michael S Conte; Patrick J Geraghty; Andrew W Bradbury; Nathanael D Hevelone; Stuart R Lipsitz; Gregory L Moneta; Mark R Nehler; Richard J Powell; Anton N Sidawy
Journal:  J Vasc Surg       Date:  2009-11-07       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.